Analyst Ratings for [A] Agilent Technologies, Inc.

10/8/25	Initiated	Buy	X
A Agilent Rothschild & Co Redburn
$165
10/8/25	Upgrades	Neutral Buy	X
A Agilent UBS
$170
2/10/25	Upgrades	Underweight Eq Weight	X
A Agilent Barclays
$135 $145
8/28/24	Initiated	Overweight	X
A Agilent Wells Fargo
$157
7/10/24	Upgrades	Neutral Buy	X
A Agilent Citigroup
$135 $150
6/27/24	Downgrades	Outperform Peer Perform	X
A Agilent Wolfe Research
6/3/24	Resumed	Hold	X
A Agilent Jefferies
$135
12/13/23	Initiated	Outperform	X
A Agilent Wolfe Research
$140
12/12/23	Downgrades	Buy Neutral	X
A Agilent BofA Securities
$130 $133
11/17/23	Downgrades	Buy Neutral	X
A Agilent UBS
$163 $125
9/28/23	Initiated	Mkt Perform	X
A Agilent Bernstein
$123
7/31/23	Downgrades	Outperform In-line	X
A Agilent Evercore ISI
$126 $124
5/24/23	Reiterated	Equal Weight	X
A Agilent Barclays
$140 $135
5/24/23	Reiterated	Buy	X
A Agilent BofA Securities
$164 $144
5/24/23	Reiterated	Neutral	X
A Agilent Citigroup
$150 $130
5/24/23	Reiterated	Outperform	X
A Agilent Credit Suisse
$170 $160
5/24/23	Reiterated	Outperform	X
A Agilent Evercore ISI
$150 $126
5/24/23	Downgrades	Overweight Sec Weight	X
A Agilent KeyBanc Capital Markets
5/24/23	Reiterated	Outperform	X
A Agilent Robert W. Baird
$174 $144
5/24/23	Reiterated	Hold	X
A Agilent Stifel
$153 $135
5/24/23	Reiterated	Outperform	X
A Agilent SVB Securities
$170 $145
5/24/23	Reiterated	Outperform	X
A Agilent TD Cowen
$168 $145
5/24/23	Reiterated	Overweight	X
A Agilent Wells Fargo
$170 $160
5/11/23	Initiated	Equal Weight	X
A Agilent Barclays
$140
1/10/23	Upgrades	Eq Weight Overweight	X
A Agilent Wells Fargo
$170
8/25/22	Initiated	Outperform	X
A Agilent Credit Suisse
$165
7/20/22	Initiated	Buy	X
A Agilent UBS
$139
7/8/22	Downgrades	Buy Neutral	X
A Agilent Citigroup
$175 $140
4/25/22	Downgrades	Overweight Eq Weight	X
A Agilent Wells Fargo
$130
3/18/21	Upgrades	Neutral Buy	X
A Agilent Citigroup
$135 $150
2/17/21	Upgrades	Neutral Buy	X
A Agilent BofA Securities
$147
7/16/19	Downgrades	Buy Neutral	X
A Agilent BofA/Merrill
$76
7/15/19	Downgrades	Overweight Eq Weight	X
A Agilent Barclays
$86 $78
6/11/19	Initiated	Overweight	X
A Agilent Piper Jaffray
$83
5/30/19	Initiated	Peer Perform	X
A Agilent Wolfe Research
3/15/19	Initiated	Buy	X
A Agilent UBS
$92
2/25/19	Reiterated	Buy	X
A Agilent Needham
$77 $88
2/21/19	Reiterated	Buy	X
A Agilent BofA/Merrill
$78 $87
1/3/19	Initiated	Buy	X
A Agilent Needham
$77
11/12/18	Downgrades	Buy Neutral	X
A Agilent Cleveland Research
4/9/18	Upgrades	Neutral Buy	X
A Agilent Goldman

A Agilent Technologies, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.